Form 4: Aytu BioPharma Director, Vivian H. Liu, Receives Restricted Stock Grant

Vivian H. Liu, a director of Aytu BioPharma, acquired 1,500 common shares through a restricted stock grant that vests on November 6, 2025, or at the next annual stockholder meeting.

Summary

• Vivian H. Liu, a director of Aytu BioPharma, filed a Form 4 to report changes in beneficial ownership.
• On November 6, 2024, Liu acquired 1,500 common shares through a grant of restricted stock.
• The restricted shares were granted at a price of $0 per share.
• These shares vest on the earlier of November 6, 2025, or at the Issuer's next annual stockholder meeting.
• Following the transaction, Liu directly owns 9,825 common shares.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a standard transaction. The grant of restricted stock is generally viewed as a positive sign, aligning director interests with shareholders, but it's a routine event.

Positives

• The grant of restricted stock to a director aligns their interests with those of the shareholders.
• The vesting schedule encourages long-term commitment from the director.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track ownership changes and potential alignment of interests.

Stakeholder Impact

• The grant of restricted stock aligns the director's interests with shareholders, potentially encouraging decisions that benefit the company's long-term value.

Key Dates

Keywords

Form 4, Beneficial Ownership, AYTU, Aytu BioPharma, Director, Restricted Stock, Vivian H. Liu